{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:51:37Z","timestamp":1787241097902,"version":"build-2736575974"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Since malignancy during pregnancy is uncommon, information regarding contraception selection or sterilization at delivery is limited. The objective of this study was to examine the type of long\u2010acting reversible contraception or surgical sterilization procedure chosen by pregnant patients with malignancy at delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>\n                      This cross\u2010sectional study queried the Healthcare Cost and Utilization Project's National Inpatient Sample in the USA. The study population was vaginal and cesarean deliveries in a hospital setting from January 2017 to December 2020. Pregnant patients with breast cancer (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091605), leukemia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091190), lymphoma (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091120), thyroid cancer (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009715), cervical cancer (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009425) and melanoma (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009400) were compared with 14\u2009265\u2009319 pregnant patients without malignancy. The main outcome measures were utilization of long\u2010acting reversible contraception (subdermal implant or intrauterine device) and performance of permanent surgical sterilization (bilateral tubal ligation or bilateral salpingectomy) during the index hospital admission for delivery, assessed with a multinomial regression model controlling for clinical, pregnancy and delivery characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When compared with pregnant patients without malignancy, pregnant patients with breast cancer were more likely to proceed with bilateral salpingectomy (adjusted odds ratio [aOR] 2.30) or intrauterine device (aOR 1.91); none received the subdermal implant. Pregnant patients with leukemia were more likely to choose a subdermal implant (aOR 2.22), whereas those with lymphoma were more likely to proceed with bilateral salpingectomy (aOR 1.93) and bilateral tubal ligation (aOR 1.76). Pregnant patients with thyroid cancer were more likely to proceed with bilateral tubal ligation (aOR 2.21) and none received the subdermal implant. No patients in the cervical cancer group selected long\u2010acting reversible contraception, and they were more likely to proceed with bilateral salpingectomy (aOR 2.08). None in the melanoma group chose long\u2010acting reversible contraception. Among pregnant patients aged &lt;30, the odds of proceeding with bilateral salpingectomy were increased in patients with breast cancer (aOR 3.01), cervical cancer (aOR 2.26) or lymphoma (aOR 2.08). The odds of proceeding with bilateral tubal ligation in pregnant patients aged &lt;30 with melanoma (aOR 5.36) was also increased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of this nationwide assessment in the United States\u00a0suggest that among pregnant patients with malignancy, the preferred contraceptive option or method of sterilization at time of hospital delivery differs by malignancy type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/aogs.14654","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T05:59:51Z","timestamp":1691992791000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contraception and sterilization selection at delivery among pregnant patients with malignancy"],"prefix":"10.1111","volume":"103","author":[{"given":"Chelsey A.","family":"Harris","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesandra R.","family":"Rau","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"},{"name":"Keck School of Medicine University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie B.","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine University of Freiburg Medical Center  Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Ouzounian","sequence":"additional","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Paulson","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"},{"name":"Norris Comprehensive Cancer Center University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California  Los Angeles California USA"},{"name":"Norris Comprehensive Cancer Center University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1363459320969775"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33137"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6503a1"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.1795"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a057a2"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2012.03475.x"},{"key":"e_1_2_12_9_1","first-page":"448","article-title":"Management of pregnant patients with cancer","volume":"30","author":"Milbourne A","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02951421"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-021-03152-0"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-15-00096"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000963"},{"key":"e_1_2_12_14_1","unstructured":"Overview of the National (Nationwide) Inpatient Sample (NIS).Agency for Healthcare Research and Quality. Accessed December 30 2022.www.hcup\u2010us.ahrq.gov\/nisoverview.jsp"},{"key":"e_1_2_12_15_1","first-page":"361","article-title":"Patient characteristics of contraception and sterilization selection at vaginal delivery","volume":"3","author":"Youssefzadeh AC","year":"2022","journal-title":"F S Rep"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.04.233"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42842"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.09.021"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14699"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001776"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000062"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25512"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0002-9378(03)00537-4"},{"key":"e_1_2_12_24_1","unstructured":"ICD\u201010.National Cancer Institute. Accessed March 10 2023.https:\/\/cancercenters.cancer.gov\/GrantsFunding\/ICD10"},{"key":"e_1_2_12_25_1","unstructured":"Basic Contraceptive Implant Coding.American College of Obstetricians and Gynecologists.2023Accessed March 10 2023.https:\/\/www.acog.org\/education\u2010and\u2010events\/publications\/larc\u2010quick\u2010coding\u2010guide\/basic\u2010contraceptive\u2010implant"},{"key":"e_1_2_12_26_1","unstructured":"Basic IUD Coding.American College of Obsetricians and Gynecologists. Accessed March 10 2023.https:\/\/www.acog.org\/education\u2010and\u2010events\/publications\/larc\u2010quick\u2010coding\u2010guide\/basic\u2010iud"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.05.021"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.06.074"},{"key":"e_1_2_12_29_1","unstructured":"How Does CDC Identify Severe Maternal Morbidity.Centers for Disease Control. Accessed March 10 2023.https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe\u2010morbidity\u2010ICD.htm"},{"key":"e_1_2_12_30_1","unstructured":"Europe UNECf.Mean age of women at birth of first child.https:\/\/w3.unece.org\/PXWeb\/en\/Table?IndicatorCode=34"},{"key":"e_1_2_12_31_1","volume-title":"Mean age of mothers is on the rise: United States, 2000\u20132014","author":"BE MTaH"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2022.100157"},{"key":"e_1_2_12_33_1","volume-title":"Healthcare cost and utilization project","author":"Producing National HCUP Estimates"},{"key":"e_1_2_12_34_1","unstructured":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Equator Network. Accesssed March 10 2023.https:\/\/www.equator\u2010network.org\/reporting\u2010guidelines\/strobe\/"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.114867"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2019.1602721"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625180801959931"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625180801942754"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X17695001"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.14654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:18:20Z","timestamp":1744294700000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.14654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1111\/aogs.14654"],"URL":"https:\/\/doi.org\/10.1111\/aogs.14654","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"2023-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}